Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise [Yahoo! Finance]
Amedisys, Inc. (NASDAQ: AMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Amedisys Reports First Quarter 2024 Financial Results [Yahoo! Finance]